Cochrane Database of Systematic Reviews 2008
DOI: 10.1002/14651858.cd007510
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum toxin for masseter hypertrophy

Abstract: Cochrane Database of Systematic Reviews Main resultsWe retrieved 683 unique references to studies. A er screening these references 660 were excluded for being non-applicable. We assessed 23 full text articles for eligibility and all of these studies were excluded from the review.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 15 publications
0
10
0
Order By: Relevance
“…Cosmetic sculpturing of the lower face using botulinum toxin has been accepted as an effective and safe alternative to invasive surgical managements [2]. However, no single conversion ratio exists between different serotypes of the toxin [12] nor have there been any comparative split-face trials using BTX-A and BTX-B for the treatment of masseter hypertrophy.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Cosmetic sculpturing of the lower face using botulinum toxin has been accepted as an effective and safe alternative to invasive surgical managements [2]. However, no single conversion ratio exists between different serotypes of the toxin [12] nor have there been any comparative split-face trials using BTX-A and BTX-B for the treatment of masseter hypertrophy.…”
Section: Discussionmentioning
confidence: 99%
“…CT scanning, considered to be the gold standard in confirming a clinical suspicion of masseter hypertrophy [2], showed a 21-30% volume reduction with BTX-A (Botox and Dysport) at 12 weeks post-treatment [6,13]. In this study, masseter volume was calculated by the reconstruction of 1-mm-thick cross-sectioned CT images in order to improve the precision and reliability of the post-treatment evaluations.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations